{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:09Z","timestamp":1772165649784,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intra-abdominal infections (IAIs) represent a most frequent gastrointestinal emergency and serious cause of morbimortality. A full classification, including all facets of IAIs, does not exist. Two classifications are used to subdivide IAIs: uncomplicated or complicated, considering infection extent; and community-acquired, healthcare-associated or hospital-acquired, regarding the place of acquisition. Adequacy of initial empirical antibiotic therapy prescribed is an essential need. Inadequate antibiotic therapy is associated with treatment failure and increased mortality. This study was designed to determine accuracy of different classifications of IAIs to identify infections by pathogens sensitive to current treatment guidelines helping the selection of the best antibiotic therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study including all adult patients discharged from hospital with a diagnosis of IAI between 1st of January and 31st of October, 2016. All variables potentially associated with pre-defined outcomes: infection by a pathogen sensitive to non-pseudomonal cephalosporin or ciprofloxacin plus metronidazole (ATB 1, primary outcome), sensitive to piperacillin-tazobactam (ATB 2) and hospital mortality (secondary outcomes) were studied through logistic regression. Accuracy of the models was assessed by area under receiver operating characteristics (AUROC) curve and calibration was tested using the Hosmer-Lemeshow goodness-of-fit test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1804 patients screened 154 met inclusion criteria. Sensitivity to ATB 1 was independently associated with male gender (adjusted OR\u2009=\u20092.612) and previous invasive procedures in the last year (adjusted OR\u2009=\u20090.424) (AUROC curve\u2009=\u20090,65). Sensitivity to ATB 2 was independently associated with liver disease (adjusted OR\u2009=\u20093.580) and post-operative infections (adjusted OR\u2009=\u20092.944) (AUROC curve\u2009=\u20090.604). Hospital mortality was independently associated with age\u2009\u2265\u200970 (adjusted OR\u2009=\u20094.677), solid tumour (adjusted OR\u2009=\u20093.127) and sensitivity to non-pseudomonal cephalosporin or ciprofloxacin plus metronidazole (adjusted OR\u2009=\u20090.368).<\/jats:p>\n                    <jats:p>The accuracy of pre-existing classifications to identify infection by a pathogen sensitive to ATB 1 was 0.59 considering place of acquisition, 0.61 infection extent and 0.57 local of infection, for ATB 2 it was 0.66, 0.50 and 0.57, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>None of existing classifications had a good discriminating power to identify IAIs caused by pathogens sensitive to current antibiotic treatment recommendations. A new classification, including patients\u2019 individual characteristics like those included in the current model, might have a higher potential to distinguish IAIs by resistant pathogens allowing a better choice of empiric antibiotic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-019-4604-0","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T09:03:34Z","timestamp":1574327014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-6396","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Silva-Nunes","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2451-4260","authenticated-orcid":false,"given":"Teresa","family":"Cardoso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"4604_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1749-7922-6-7","volume":"6","author":"N Lopez","year":"2011","unstructured":"Lopez N, Kobayashi L, Coimbra R. A comprehensive review of abdominal infections. World J Emerg Surg. 2011;6:7.","journal-title":"World J Emerg Surg"},{"issue":"18","key":"4604_CR2","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s40265-015-0506-7","volume":"75","author":"YR Lee","year":"2015","unstructured":"Lee YR, et al. Complicated intra-abdominal infections: the old antimicrobials and the new players. Drugs. 2015;75(18):2097\u2013117.","journal-title":"Drugs"},{"issue":"2","key":"4604_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.accpm.2015.03.005","volume":"34","author":"P Montravers","year":"2015","unstructured":"Montravers P, et al. Guidelines for management of intra-abdominal infections. Anaesth Crit Care Pain Med. 2015;34(2):117\u201330.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"1","key":"4604_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/antibiotics5010011","volume":"5","author":"Charles Hoffmann","year":"2016","unstructured":"Hoffmann C, et al. Treatment Modalities and Antimicrobial Stewardship Initiatives in the Management of Intra-Abdominal Infections. Antibiotics (Basel). 2016;5(1). https:\/\/doi.org\/10.3390\/antibiotics5010011.","journal-title":"Antibiotics"},{"issue":"7","key":"4604_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1017\/ice.2016.64","volume":"37","author":"LL Huang","year":"2016","unstructured":"Huang LL, et al. Guideline-concordant versus discordant antimicrobial therapy in patients with community-onset complicated intra-abdominal infections. Infect Control Hosp Epidemiol. 2016;37(7):855\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4604_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13017-016-0089-y","volume":"11","author":"M Sartelli","year":"2016","unstructured":"Sartelli M, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016;11:33.","journal-title":"World J Emerg Surg"},{"issue":"6","key":"4604_CR7","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.2165\/11599800-000000000-00000","volume":"72","author":"S Blot","year":"2012","unstructured":"Blot S, De Waele JJ, Vogelaers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs. 2012;72(6):e17\u201332.","journal-title":"Drugs"},{"issue":"Suppl 1","key":"4604_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/joc.2009.21.Supplement-1.3","volume":"21","author":"F Menichetti","year":"2009","unstructured":"Menichetti F, Sganga G. Definition and classification of intra-abdominal infections. J Chemother. 2009;21(Suppl 1):3\u20134.","journal-title":"J Chemother"},{"issue":"1","key":"4604_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1749-7922-8-3","volume":"8","author":"M Sartelli","year":"2013","unstructured":"Sartelli M, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013;8(1):3.","journal-title":"World J Emerg Surg"},{"key":"4604_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1749-7922-5-9","volume":"5","author":"M Sartelli","year":"2010","unstructured":"Sartelli M. A focus on intra-abdominal infections. World J Emerg Surg. 2010;5:9.","journal-title":"World J Emerg Surg"},{"key":"4604_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13017-015-0013-x","volume":"10","author":"B De Simone","year":"2015","unstructured":"De Simone B, et al. Benefits of WSES guidelines application for the management of intra-abdominal infections. World J Emerg Surg. 2015;10:18.","journal-title":"World J Emerg Surg"},{"issue":"9","key":"4604_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3748\/wjg.v18.i9.865","volume":"18","author":"M Sartelli","year":"2012","unstructured":"Sartelli M, et al. Antimicrobial management of intra-abdominal infections: literature's guidelines. World J Gastroenterol. 2012;18(9):865\u201371.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4604_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133\u201364.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4604_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1086\/378702","volume":"37","author":"JS Solomkin","year":"2003","unstructured":"Solomkin JS, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37(8):997\u20131005.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4604_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/jac\/dkp005","volume":"63","author":"P Montravers","year":"2009","unstructured":"Montravers P, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009;63(4):785\u201394.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4604_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1749-7922-7-36","volume":"7","author":"M Sartelli","year":"2012","unstructured":"Sartelli M, et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J Emerg Surg. 2012;7(1):36.","journal-title":"World J Emerg Surg"},{"key":"4604_CR17","unstructured":"Garner, J.S., et al., [CDC definitions for nosocomial infections 1988]. Z Arztl Fortbild (Jena), 1991 85(17): p. 818\u201327."},{"key":"4604_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1741-7015-12-40","volume":"12","author":"T Cardoso","year":"2014","unstructured":"Cardoso T, et al. Classification of healthcare-associated infection: a systematic review 10 years after the first proposal. BMC Med. 2014;12:40.","journal-title":"BMC Med"},{"issue":"10","key":"4604_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791\u20137.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4604_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/bja\/aew117","volume":"117","author":"M Guilbart","year":"2016","unstructured":"Guilbart M, et al. Compliance with an empirical antimicrobial protocol improves the outcome of complicated intra-abdominal infections: a prospective observational study. Br J Anaesth. 2016;117(1):66\u201372.","journal-title":"Br J Anaesth"},{"issue":"9","key":"4604_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s10096-004-1199-0","volume":"23","author":"K Krobot","year":"2004","unstructured":"Krobot K, et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004;23(9):682\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 3","key":"4604_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1469-0691.2008.01959.x","volume":"14","author":"PG Davey","year":"2008","unstructured":"Davey PG, Marwick C. Appropriate vs. inappropriate antimicrobial therapy. Clin Microbiol Infect. 2008;14(Suppl 3):15\u201321.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4604_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/109629602761624171","volume":"3","author":"JE Mazuski","year":"2002","unstructured":"Mazuski JE, et al. The surgical infection society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect. 2002;3(3):161\u201373.","journal-title":"Surg Infect"},{"key":"4604_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1749-7922-6-2","volume":"6","author":"M Sartelli","year":"2011","unstructured":"Sartelli M, et al. WSES consensus conference: guidelines for first-line management of intra-abdominal infections. World J Emerg Surg. 2011;6:2.","journal-title":"World J Emerg Surg"},{"issue":"4","key":"4604_CR25","first-page":"303","volume":"161","author":"AE Yellin","year":"1985","unstructured":"Yellin AE, et al. The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet. 1985;161(4):303\u20137.","journal-title":"Surg Gynecol Obstet"},{"issue":"5","key":"4604_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00000658-199111000-00001","volume":"214","author":"DM Mosdell","year":"1991","unstructured":"Mosdell DM, et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 1991;214(5):543\u20139.","journal-title":"Ann Surg"},{"issue":"1","key":"4604_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0002-9610(82)90594-3","volume":"144","author":"TV Berne","year":"1982","unstructured":"Berne TV, et al. Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone. Am J Surg. 1982;144(1):8\u201313.","journal-title":"Am J Surg"},{"issue":"12","key":"4604_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/BF01690508","volume":"15","author":"ME Falagas","year":"1996","unstructured":"Falagas ME, et al. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin\/soft tissue infections. Eur J Clin Microbiol Infect Dis. 1996;15(12):913\u201321.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"4604_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2125.2005.02443.x","volume":"60","author":"MC Sturkenboom","year":"2005","unstructured":"Sturkenboom MC, et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol. 2005;60(4):438\u201343.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"4604_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/clinids\/23.3.486","volume":"23","author":"P Montravers","year":"1996","unstructured":"Montravers P, et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis. 1996;23(3):486\u201394.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4604_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1186\/s12913-017-2683-4","volume":"17","author":"E Feiring","year":"2017","unstructured":"Feiring E, Walter AB. Antimicrobial stewardship: a qualitative study of the development of national guidelines for antibiotic use in hospitals. BMC Health Serv Res. 2017;17(1):747.","journal-title":"BMC Health Serv Res"},{"key":"4604_CR32","unstructured":"Karnofsky, D.A. and J.H. Burchenal, The Clinical Evaluation of Chemotherapeutic Agents in Cancer. C. M. MacLeod, Ed., 1949(Evaluation of Chemotherapeutic Agents, Columbia University Press): p. 196."},{"issue":"5","key":"4604_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"2","key":"4604_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/liv.12625","volume":"35","author":"K Sargenti","year":"2015","unstructured":"Sargenti K, et al. Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome. Liver Int. 2015;35(2):391\u2013400.","journal-title":"Liver Int"},{"issue":"5","key":"4604_CR35","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.28332","volume":"63","author":"M Merli","year":"2016","unstructured":"Merli M, et al. An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: a randomized trial. Hepatology. 2016;63(5):1632\u20139.","journal-title":"Hepatology"},{"issue":"11","key":"4604_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1001\/archsurg.1996.01430230075014","volume":"131","author":"NV Christou","year":"1996","unstructured":"Christou NV, et al. Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian intra-abdominal infection study group. Arch Surg. 1996;131(11):1193\u2013201.","journal-title":"Arch Surg"},{"issue":"12","key":"4604_CR37","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/archsurg.1997.01430360040008","volume":"132","author":"PS Barie","year":"1997","unstructured":"Barie PS, et al. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime intra-abdominal infection study group. Arch Surg. 1997;132(12):1294\u2013302.","journal-title":"Arch Surg"},{"issue":"12","key":"4604_CR38","first-page":"791","volume":"59","author":"JA Hopkins","year":"1993","unstructured":"Hopkins JA, Lee JC, Wilson SE. Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection. Am Surg. 1993;59(12):791\u20136.","journal-title":"Am Surg"},{"issue":"2","key":"4604_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cjtee.2015.07.003","volume":"18","author":"S Zhang","year":"2015","unstructured":"Zhang S, Huang W. Epidemiological study of community- and hospital-acquired intraabdominal infections. Chin J Traumatol. 2015;18(2):84\u20139.","journal-title":"Chin J Traumatol"},{"key":"4604_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1749-7922-9-37","volume":"9","author":"M Sartelli","year":"2014","unstructured":"Sartelli M, et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW study. World J Emerg Surg. 2014;9:37.","journal-title":"World J Emerg Surg"},{"issue":"3","key":"4604_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1089\/sur.2011.039","volume":"15","author":"JA Claridge","year":"2014","unstructured":"Claridge JA, et al. Bacterial species-specific hospital mortality rate for intra-abdominal infections. Surg Infect. 2014;15(3):194\u20139.","journal-title":"Surg Infect"},{"issue":"1","key":"4604_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/sur.2015.127","volume":"17","author":"PM Shah","year":"2016","unstructured":"Shah PM, et al. Do Polymicrobial intra-abdominal infections have worse outcomes than Monomicrobial intra-abdominal infections? Surg Infect. 2016;17(1):27\u201331.","journal-title":"Surg Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4604-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4604-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4604-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T19:57:53Z","timestamp":1605815873000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4604-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4604"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4604-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.12220\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12220\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12220\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12220\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee, Departamento de Ensino, Forma\u00e7\u00e3o e Investiga\u00e7\u00e3o (DEFI) of Centro Hospitalar Universit\u00e1rio do Porto (CHUP) - ref. 2017.226(195-DEFI\/187-CES). The need for consent was waived by the local ethics committee and patient data was de-identified.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"980"}}